Literature DB >> 12849079

Regional cerebral blood flow and EEG in clinically diagnosed dementia with Lewy bodies and Alzheimer's disease.

Elisabet Londos1, Ulla Passant, Arne Brun, Ingmar Rosén, Jarl Risberg, Lars Gustafson.   

Abstract

This study was undertaken in order to compare regional cerebral blood flow (rCBF) and EEG findings of patients with clinically diagnosed dementia with Lewy bodies (clinDLB) and Alzheimer's disease (clinAD). Furthermore, within the clinDLB group to compare cases with and without neuropathologically verified Lewy bodies (LBs). When we studied 200 dementia cases in a prospective longitudinal dementia study, 48 had clinDLB and 45 clinAD in retrospective analyses. EEG information was analysed in 34 clinDLB and 28 clinAD patients and cerebral blood flow, measured with the Xe 133 inhalation method, in 26 clinDLB and 25 clinAD. There were no differences in EEG between the clinDLB and clinAD groups or between the cases with and without LBs. The rCBF patterns in the clinDLB and clinAD groups showed similar reductions in the temporoparietal areas. The rCBF in cases with LBs showed heterogeneous pathology. The imaging results in clinDLB and clinAD were strikingly similar. The EEG and rCBF could not differentiate between cases with or without LB. The study illustrates the lack of specific changes of EEG and rCBF in cases with LB pathology.

Entities:  

Mesh:

Year:  2003        PMID: 12849079     DOI: 10.1016/s0167-4943(02)00168-1

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  2 in total

Review 1.  Electroencephalogram in dementia with Lewy bodies: a systematic review.

Authors:  Simela Chatzikonstantinou; Jack McKenna; Eleni Karantali; Fivos Petridis; Dimitrios Kazis; Ioannis Mavroudis
Journal:  Aging Clin Exp Res       Date:  2020-05-07       Impact factor: 3.636

Review 2.  Neurophysiological biomarkers for Lewy body dementias.

Authors:  Ruth A Cromarty; Greg J Elder; Sara Graziadio; Mark Baker; Laura Bonanni; Marco Onofrj; John T O'Brien; John-Paul Taylor
Journal:  Clin Neurophysiol       Date:  2015-06-27       Impact factor: 3.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.